Literature DB >> 8141229

Functional characteristics of small placental arteries.

A L McCarthy1, R G Woolfson, B J Evans, D R Davies, S K Raju, L Poston.   

Abstract

OBJECTIVES: The aim of this study was to investigate characteristics of placental arteries capable of influencing vasomotor tone in the fetoplacental vascular bed. Contractile characteristics and endothelium-dependent and endothelium-independent relaxation were examined. STUDY
DESIGN: By means of a small vessel myograph arteries of mean normalized internal diameter 353.22 +/- 13.14 microns were studied under isometric conditions. Contractile function was assessed with a variety of agonists, including angiotensin II, endothelin-1, the thromboxane mimetic U46619, prostaglandin E2, and prostaglandin F2 alpha. The effect of physiologic and supraphysiologic PO2 on vascular function was also examined. Relaxation was assessed in response to known endothelium-dependent vasodilators, including acetylcholine, bradykinin, histamine, and A23187 and to sodium nitroprusside (endothelium independent). The effect of indomethacin and the nitric oxide synthase inhibitor, NG-nitro-L-arginine methyl ester on contractile function was also evaluated.
RESULTS: Sensitivity to sodium nitroprusside was reduced by a high PO2. U46619 was the most potent constrictor agonist studied. The response of precontracted arteries to known endothelium-dependent vasodilators was minimal, other than for histamine, which led to modest relaxation. The constrictor response to U46619 was increased in the presence of NG-nitro-L-arginine methyl ester.
CONCLUSIONS: Oxygen tension may be an important determinant of relaxation in small placental arteries. Receptor-mediated release of endothelium-derived relaxing factor is not a major mechanism in the fetoplacental circulation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8141229     DOI: 10.1016/s0002-9378(94)70311-6

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  8 in total

Review 1.  Angiotensin II regulation of ovine fetoplacental artery endothelial functions: interactions with nitric oxide.

Authors:  Jing Zheng; Ian M Bird; Dong-Bao Chen; Ronald R Magness
Journal:  J Physiol       Date:  2005-03-24       Impact factor: 5.182

Review 2.  Role of the fetoplacental endothelium in fetal growth restriction with abnormal umbilical artery Doppler velocimetry.

Authors:  Emily J Su
Journal:  Am J Obstet Gynecol       Date:  2015-10       Impact factor: 8.661

3.  Nitric oxide synthase in human placenta and umbilical cord from normal, intrauterine growth-retarded and pre-eclamptic pregnancies.

Authors:  R A Rutherford; A McCarthy; M H Sullivan; M G Elder; J M Polak; J Wharton
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

Review 4.  Molecular and cellular underpinnings of normal and abnormal human placental blood flows.

Authors:  Yingchun Li; Ramón A Lorca; Emily J Su
Journal:  J Mol Endocrinol       Date:  2017-11-02       Impact factor: 5.098

5.  Modulation of body fluids and angiotensin II receptors in a rat model of intra-uterine growth restriction.

Authors:  Sophie Bédard; Benoit Sicotte; Jean St-Louis; Michèle Brochu
Journal:  J Physiol       Date:  2004-11-11       Impact factor: 5.182

6.  New conception for the development of hypertension in preeclampsia.

Authors:  Qinqin Gao; Jiaqi Tang; Na Li; Xiuwen Zhou; Xiaolin Zhu; Weisheng Li; Bailin Liu; Xueqin Feng; Jianying Tao; Bing Han; Hong Zhang; Miao Sun; Zhice Xu
Journal:  Oncotarget       Date:  2016-11-29

Review 7.  Roles of nitric oxide and asymmetric dimethylarginine in pregnancy and fetal programming.

Authors:  Li-Tung Huang; Chih-Sung Hsieh; Kow-Aung Chang; You-Lin Tain
Journal:  Int J Mol Sci       Date:  2012-11-09       Impact factor: 5.923

8.  Chorionic plate arterial function is altered in maternal obesity.

Authors:  C E Hayward; L Higgins; E J Cowley; S L Greenwood; T A Mills; C P Sibley; M Wareing
Journal:  Placenta       Date:  2013-01-27       Impact factor: 3.481

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.